Skip to main content
logo
Centessa Pharmaceuticals plc (CNTA)
Jun 24, 2026 - CNTA was delisted (reason: acquired by LLY)
40.50
+0.32 (0.80%)
Inactive · Last trade price on Jun 23, 2026

Centessa Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-15-6.85--
Revenue Growth
------
Gross Profit
-15-6.85--
Operating Income
-256.69-207.69-201.06-171.28-210.28-139.33
Net Income
-250.64-197.53-235.76-151.09-216.21-381.07
Earnings Per Share
-1.78-1.46-2.06-1.57-2.31-5.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
276.59294.58482.18256.55393.64595.08
Total Debt
118.56118.38117.8384.5969.875.7
Net Cash (Debt)
158.03176.2364.35171.96323.84519.38
Net Cash Growth
-5.09%-51.64%111.88%-46.90%-37.65%32361.38%
Net Cash Per Share
1.121.303.181.793.476.91

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-208.8-193.82-142.06-160.34-200.55-136.16
Capital Expenditures
-0.37-0.37-0.03-0.17-1.14-0.19
Free Cash Flow
-209.17-194.19-142.09-160.51-201.68-136.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%-100.00%--
Operating Margin
--1384.61%--2499.39%--
Pretax Margin
--1304.75%--2570.28%--
Profit Margin
--1316.88%--2204.66%--
FCF Margin
--1294.59%--2342.20%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-243.56-113.40--